In this randomized controlled trial in participants with nonalcoholic fatty liver disease, berberine didn’t have much of an effect on liver health metrics or cardiovascular disease risk factors, but discrepancies in the data limit confidence in these findings.
This Study Summary was published on October 22, 2024.
